Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tumor necrosis factor alpha inhibitor | Is a | Biological agent | false | Inferred relationship | Some | ||
| Tumor necrosis factor alpha inhibitor | Is a | Immunomodulator | true | Inferred relationship | Some | ||
| Tumor necrosis factor alpha inhibitor | Is a | Anti-inflammatory agent | false | Inferred relationship | Some | ||
| Tumor necrosis factor alpha inhibitor | Has disposition (attribute) | Tumor necrosis factor alpha inhibitor (disposition) | true | Inferred relationship | Some | ||
| Tumor necrosis factor alpha inhibitor | Is a | Drug or medicament (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Adalimumab (substance) | Is a | True | Tumor necrosis factor alpha inhibitor | Inferred relationship | Some | |
| Infliximab (substance) | Is a | True | Tumor necrosis factor alpha inhibitor | Inferred relationship | Some | |
| Etanercept (substance) | Is a | True | Tumor necrosis factor alpha inhibitor | Inferred relationship | Some | |
| Product containing tumor necrosis factor alpha inhibitor (product) | Has active ingredient | True | Tumor necrosis factor alpha inhibitor | Inferred relationship | Some | 1 |
| Certolizumab pegol (substance) | Is a | True | Tumor necrosis factor alpha inhibitor | Inferred relationship | Some | |
| Golimumab | Is a | True | Tumor necrosis factor alpha inhibitor | Inferred relationship | Some |
Reference Sets